Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
about
New ethanol and propylene glycol free gel formulations containing a minoxidil-methyl-β-cyclodextrin complex as promising tools for alopecia treatment.Characterisation and Skin Distribution of Lecithin-Based Coenzyme Q10-Loaded Lipid NanocapsulesNanotechnology in cosmetics: Opportunities and challenges.Preparation and evaluation of minoxidil foamable emu oil emulsionQbD-based carbopol transgel formulation: characterization, pharmacokinetic assessment and therapeutic efficacy in diabetes.Development of nanovesicular systems for dermal imiquimod delivery: physicochemical characterization and in vitro/in vivo evaluation.Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity.Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive BladderCharged liposomes as carriers to enhance the permeation through the skin.Niosomes as a propitious carrier for topical drug delivery.Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations.Colloidal drug delivery system: amplify the ocular delivery.In vitro and in vivo investigation for optimization of niosomal ability for sustainment and bioavailability enhancement of diltiazem after nasal administration.Formulation of tretinoin-loaded topical proniosomes for treatment of acne: in-vitro characterization, skin irritation test and comparative clinical study.Enhanced in vitro cellular uptake of P-gp substrate by poloxamer-modified liposomes (PMLs) in MDR cancer cells.Serratiopeptidase Niosomal Gel with Potential in Topical Delivery.Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design.Etodolac Containing Topical Niosomal Gel: Formulation Development and Evaluation.Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge.Vancomycin-eluting niosomes: a new approach to the inhibition of staphylococcal biofilm on abiotic surfaces.Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel.Preformulation, formulation, and in vivo efficacy of topically applied apomine.pH-sensitive pHLIP® coated niosomes.In Vitro and In Vivo Evaluation of Niosomal Formulation for Controlled Delivery of ClarithromycinNiosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin.Niosomal encapsulation of ethambutol hydrochloride for increasing its efficacy and safety.Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.Novel in situ gelling ocular inserts for voriconazole-loaded niosomes: design, in vitro characterisation and in vivo evaluation of the ocular irritation and drug pharmacokinetics.Novel non-ionic surfactant proniosomes for transdermal delivery of lacidipine: optimization using 2(3) factorial design and in vivo evaluation in rabbits.Minoxidil Induction of VEGF Is Mediated by Inhibition of HIF-Prolyl Hydroxylase.Minoxidil Skin Delivery from Nanoemulsion Formulations Containing Eucalyptol or Oleic Acid: Enhanced Diffusivity and Follicular Targeting.Germacrone and sesquiterpene-enriched extracts from Curcuma aeruginosa Roxb. increase skin penetration of minoxidil, a hair growth promoter.Improved hepatoprotective activity of silymarin via encapsulation in the novel vesicular nanosystem bilosomes.Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery.Effect of formulation compositions on niosomal preparations.Optimization of minoxidil microemulsions using fractional factorial design approach.Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.Formulation by design-based proniosome for accentuated transdermal delivery of risperidone: in vitro characterization and in vivo pharmacokinetic study.Formulation and evaluation of proniosomes containing lornoxicam.Transdermal delivery of oxybutynin chloride proniosomal gels for the treatment of overactive bladder.
P2860
Q30781549-C1866AB8-878E-4DF7-A5FD-F70E773F5485Q34205341-7295C160-B930-4407-8F4B-7C291CB85E5BQ34296083-027599B7-BA55-4C30-AE67-3C3D1B8FCCF5Q35029649-EC9F3ABF-535F-43A6-9F4B-C3E1F2F94B1AQ35208156-E13F4B73-A3DA-4A86-9563-63274B0FC551Q35635404-EF6CD075-0246-4A6A-A61A-8702E665751DQ37126399-F39FD68B-A3BB-49C5-AF51-A8BB342DA53EQ37290722-E454703A-35C5-4FCE-8EB8-55F98A5B76D1Q37873946-EB3DC3E7-335F-436A-9461-F42F09E829DAQ38068500-71B16BE3-4659-44CC-9077-FF9EBEF080A9Q38155210-D41604A7-60BD-4B30-A81C-25DE64D00854Q38217270-804BEB5B-FBAA-478F-9C92-4B2231D4E74FQ38760966-9C11DFA6-1B78-4831-9900-4344396FB7E6Q39378497-7F2D167C-6012-4053-A01D-83B1F7177636Q39504361-4426E492-98BA-416D-B8FE-E4564ECEE3B6Q41496823-F2D179BD-FA16-44BB-B2B4-5DDD35184497Q41500018-BBF06E68-74EC-440B-B425-ED7E13B2CE4DQ41817566-717EFCF1-185D-4E5D-9D57-E51126FEA1FEQ41871280-55AA77E3-041D-41B5-8914-026B1FF21667Q41885249-451D40FE-C05B-4658-90DB-93E1435738B7Q41988134-1F982AD1-F8D0-4E19-A5E7-961D58CD3F40Q42149365-AB174A49-6E13-430D-B7F8-FAE29EA2C374Q42623230-D4B4EC0D-B4BB-4E54-83B0-3FE4B148B7CBQ42753033-E395B84C-B15D-4A9C-B3AB-B72EB88E4745Q44837755-C9524C66-19CF-4EDD-AE66-1D8145C86D42Q46528246-53AC8B00-3C28-4D77-BE50-21A893D9C8E8Q46754307-28522C9F-01C6-4BB2-84B2-B37CE8CFDC98Q46844328-90F82A4F-30E0-4457-BCCB-D92C98404538Q46902877-07711894-3E77-4296-9638-CF1C4CF36C68Q47218522-70B032B5-797C-452D-B8FD-15126D4E80A9Q47700876-05BA72DC-98D0-44DC-8CA3-86DC6E3359EBQ48265876-5DC03C67-4AE9-4A22-91C6-B01DC4463882Q48324641-A4CD98EF-23C2-4D8E-879E-4D7ACA7831CEQ50072089-4D239FD1-3858-47AD-B180-36E8F7D591A1Q50249189-5A2A5F60-625D-487A-A045-E282A10F7D46Q51024616-D98899CF-B125-410E-93E9-F1C4E1FC21C7Q51731998-589793B9-AECA-46A6-A5E0-6248105F6B7AQ51756206-211C97C4-3FBF-4AA7-84FE-4E106A77A0DAQ53089921-D5FDE45B-E4CF-498C-8891-804B2A6CE0ADQ53254489-215AF2A9-F86F-42BD-9EFD-6F4F563652CB
P2860
Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
@ast
Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
@en
Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
@nl
type
label
Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
@ast
Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
@en
Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
@nl
prefLabel
Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
@ast
Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
@en
Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
@nl
P2093
P1476
Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery
@en
P2093
Bong Kyu Yoo
Chul Soon Yong
Dae-Duk Kim
Dong Hoon Oh
Han-Gon Choi
Jong Oh Kim
Jong Soo Woo
Jung Sun Kim
Prabagar Balakrishnan
Won Mo Lee
P356
10.1016/J.IJPHARM.2009.04.020
P407
P577
2009-04-24T00:00:00Z